Epoch Biodesign
Epoch Biodesign develops enzymatic recycling technology to transform plastic waste into virgin-quality polymers, specifically focusing on nylon 6,6. The company uses an AI-driven platform to design enzymes that deconstruct materials at the molecular level for reuse in the apparel, automotive, and industrial sectors. Their process operates at a multi-tonne scale to provide drop-in recycled materials with lower emissions than traditional manufacturing.
Visit websiteLondon, UK
Climate Tech
Circular Economy
Biotechnology
Advanced Materials
Funding summary
- Total raised
- €37.9M
- Funding rounds
- 3
Investors in Epoch Biodesign
Investors on record for Epoch Biodesign. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Epoch Biodesign?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors